Home/Exuma Biotechnology/Gregory Frost, Ph.D.
GF

Gregory Frost, Ph.D.

Chairman & Chief Executive Officer

Exuma Biotechnology

Exuma Biotechnology Pipeline

DrugIndicationPhase
Autologous HER2 Directed TMR CAR-TSolid Tumors (e.g., GI Cancers)Phase 1